NGM Biopharmaceuticals (NGM) PT Lowered to $25 at B.Riley, Following Clinical Business Update
Tweet Send to a Friend
B.Riley analyst Yuan Zhi lowered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
